Study finds combined pharma + non-pharma treatment most beneficial to help youth with ADHD address long-term academic difficulties

By Dr. David Rabiner | February 10, 2020

__ Aca­d­e­m­ic dif­fi­cul­ties are one of the most impor­tant adverse con­se­quences of ADHD, and they fre­quent­ly con­tribute to par­ents’ deci­sion to seek treat­ment for their child. Whether treat­ment con­sis­tent­ly yields a pos­i­tive impact on long-term aca­d­e­m­ic suc­cess is thus an impor­tant issue; how­ev­er, the answer to this ques­tion has been some­what controversial.

Read More